U.S. federal trademark · Serial No. 87878032 · Reg. No. 5778925
Research and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder (ADHD); conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention- deficit/hyperactivity disorder (ADHD)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.